AMRX
Amneal Pharmaceuticals, Inc. Class A Common Stock
NASDAQ: AMRX · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$12.80
+0.51% today
Updated 2026-04-29
Market cap
$4.08B
P/E ratio
58.18
P/S ratio
1.35x
EPS (TTM)
$0.22
Dividend yield
—
52W range
$7 – $15
Volume
1.9M
Amneal Pharmaceuticals, Inc. Class A Common Stock (AMRX) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $112.26M | $104.88M | $115.06M | $234.19M | $250.23M | $1.71M | $379.00M | $241.82M | $65.10M | $345.58M | $295.10M | $339.99M |
| Capital expenditures | $79.38M | $117.38M | $124.61M | $114.27M | $97.09M | $97.43M | $61.84M | $47.73M | $90.59M | $69.19M | $74.99M | $70.06M |
| Depreciation | — | — | — | — | — | — | — | — | — | — | — | — |
| Stock-based comp | — | — | $21.40M | $4.71M | $167.60M | $21.68M | $20.75M | $28.41M | $31.85M | $26.82M | $27.77M | $31.95M |
| Free cash flow | $32.87M | $-12.50M | $-9.55M | $119.92M | $153.14M | $-95.73M | $317.17M | $194.09M | $-25.50M | $276.39M | $220.11M | $269.93M |
| Investing cash flow | — | — | — | — | — | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — | — | — | — | — | — |
| Dividends paid | $243.00M | $258.17M | $200.62M | $375.26M | $183.00M | $0.00 | — | — | $3.57M | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | — | $141.53M | $-63.71M | $193.26M | $-90.48M | $-215.83M | — | — | — |